(HealthDay)—For high-risk patients with implantable cardioverter-defibrillators (ICDs), ranolazine does not significantly reduce the risk of ventricular tachycardia (VT) or ventricular fibrillation (VF) requiring appropriate ...
Sep 18, 2018
0
0
A clinical trial of more than 1,000 patients with implantable cardioverter defibrillators (ICDs) found that the drug ranolazine (commonly used to treat chest pain; brand name Ranexa) was safe but didn't significantly decrease ...
Aug 28, 2018
0
5
Peter Ruben and his team of researchers have spent years studying why seemingly healthy patients with inherited cardiac arrhythmias can sometimes suddenly die during exercise. (2017, 2016, 2015) His past research has shown ...
Mar 08, 2018
0
1
(HealthDay)—The drug Ranexa (ranolazine) may help reduce chest pain in people with type 2 diabetes, a new study finds.
Mar 11, 2013
0
0
An international research team, led from the University of Leeds, has found that a common anti-angina drug could help protect the heart against carbon monoxide poisoning.
Aug 06, 2012
0
0
Ranolazine (Ranexa, Gilead) is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented ...
Apr 04, 2011
0
0
